{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:07:15Z","timestamp":1792296435758,"version":"4.4.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Atopic dermatitis (AD) is a chronic, recurrent inflammatory skin disease with a wide range of heterogeneity. Accurate biomarkers or predictors are the keys to instructing personalized tailored precise treatment. The development of technology such as transcriptomics, genomics, and proteomics provides novel insights into the possibility to find potential biomarkers. Meanwhile, emerging minimally invasive methods such as tape stripping were used to reveal different profiles of patients\u2019 skin without biopsy. Several potential biomarkers or predictors have been found. In this review, we summarized the current development of potential biomarkers of AD. Nitric oxide synthase 2\/inducible nitric oxide synthase (NOS2\/iNOS), human beta-defensin-2 (hBD-2), and matrix metalloproteinases 8\/9 (MMP8\/9) may be the candidate biomarkers for AD diagnosis. Filaggrin (FLG) gene mutation increased the occurrence risk of AD. Fatty-acid-binding protein 5 (FABP5) may serve as an effective biomarker for the atopic march (AM). Squamous cell carcinoma antigen 2 (SCCA2), serum thymus and activation-regulated chemokine (TARC), cutaneous T-cell-attracting chemokine (CTACK), eosinophil-derived neurotoxin (EDN), macrophage-derived chemokine (MDC), lactate dehydrogenase (LDH), and interleukin (IL)-18 can be the candidate biomarkers for disease severity monitoring. IL-17, IL-23, IL-33, and indoleamine 2,3-dioxygenase (IDO1) can be used as predictive biomarkers for AD comorbidities. LDH, TARC, pulmonary and activation-regulated chemokine (PARC), periostin, IL-22, eotaxin-1\/3, and IL-8 may be the candidate biomarkers for monitoring treatment effects. There are still unmet needs and a long way to go for more convenient, non-invasive, and effective predictors and biomarkers to better guide personalized precise treatment.<\/jats:p>","DOI":"10.3389\/fmed.2022.1028694","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T05:02:06Z","timestamp":1668661326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Potential biomarkers of atopic dermatitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Ling","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC phase three.","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpeds.2015.10.077","article-title":"The financial and emotional impact of atopic dermatitis on children and their families.","volume":"169","author":"Filanovsky","year":"2016","journal-title":"J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis.","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/all.12112","article-title":"Characterization of different courses of atopic dermatitis in adolescent and adult patients.","volume":"68","author":"Garmhausen","year":"2013","journal-title":"Allergy."},{"key":"B5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Guidelines for management of atopic dermatitis.","volume":"36","author":"Saeki","year":"2009","journal-title":"J Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4103\/0366-6999.178960","article-title":"Clinical features of adult\/adolescent atopic dermatitis and chinese criteria for atopic dermatitis.","volume":"129","author":"Liu","year":"2016","journal-title":"Chin Med J (Engl)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.aller.2019.07.008","article-title":"Diagnosis of atopic dermatitis in children: comparison of the Hanifin-Rajka and the United Kingdom working party criteria.","volume":"48","author":"Akan","year":"2020","journal-title":"Allergol Immunopathol (Madr)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jaci.2017.01.008","article-title":"Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go.","volume":"139","author":"Bieber","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.det.2017.02.012","article-title":"Atopic dermatitis: racial and ethnic differences.","volume":"35","author":"Mei-Yen Yong","year":"2017","journal-title":"Dermatol Clin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1610-0387.2010.07508.x","article-title":"Phenotypes of atopic dermatitis.","volume":"9","author":"Pugliarello","year":"2011","journal-title":"J Dtsch Dermatol Ges."},{"key":"B11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2018.09.035","article-title":"A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics.","volume":"80","author":"Yew","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis.","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02727","article-title":"Leveraging multilayered \u201cOmics\u201d data for atopic dermatitis: a road map to precision medicine.","volume":"9","author":"Ghosh","year":"2018","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.","volume":"82","author":"Pavel","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2019.11.004","article-title":"The skin microbiome as a clinical biomarker in atopic eczema: promises, navigation, and pitfalls.","volume":"145","author":"Reiger","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jaci.2020.03.041","article-title":"Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis.","volume":"146","author":"Rojahn","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000448400","article-title":"Stratum corneum tape stripping: monitoring of inflammatory mediators in atopic dermatitis patients using topical therapy.","volume":"170","author":"Koppes","year":"2016","journal-title":"Int Arch Allergy Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2020.05.048","article-title":"Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis.","volume":"147","author":"He","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.anai.2020.08.397","article-title":"Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin.","volume":"126","author":"Lyubchenko","year":"2021","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bjd.19760","article-title":"Tape strips in dermatology research.","volume":"185","author":"Hughes","year":"2021","journal-title":"Br J Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/jid.2014.532","article-title":"IL-36\u03b3 (IL-1F9) is a biomarker for psoriasis skin lesions.","volume":"135","author":"D\u2019Erme","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/1346-8138.14198","article-title":"Increased interleukin-36\u03b3 expression in skin and sera of patients with atopic dermatitis and mycosis fungoides\/S\u00e9zary syndrome.","volume":"45","author":"Otobe","year":"2018","journal-title":"J Dermatol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004725","article-title":"Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.","volume":"4","author":"Jansen","year":"2009","journal-title":"PLoS One."},{"key":"B25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/exd.13077","article-title":"A novel molecular disease classifier for psoriasis and eczema.","volume":"25","author":"Garzorz-Stark","year":"2016","journal-title":"Exp Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2133.2009.09547.x","article-title":"Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis.","volume":"162","author":"Kamsteeg","year":"2010","journal-title":"Br J Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s004280050179","article-title":"Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study.","volume":"432","author":"Urashima","year":"1998","journal-title":"Virchows Arch."},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2133.2009.09467.x","article-title":"A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis.","volume":"162","author":"Harper","year":"2010","journal-title":"Br J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100828R","article-title":"Urinary lipid profile of atopic dermatitis in murine model and human patients.","volume":"35","author":"Nagata","year":"2021","journal-title":"FASEB J."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01907","article-title":"Research progress in atopic march.","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1289\/ehp.1408700","article-title":"Perinatal exposure to traffic-related air pollution and atopy at 1 year of age in a multi-center canadian birth cohort study.","volume":"123","author":"Sbihi","year":"2015","journal-title":"Environ Health Perspect."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00913-2019","article-title":"Early life exposure to air pollution and incidence of childhood asthma, allergic rhinitis and eczema.","volume":"55","author":"To","year":"2020","journal-title":"Eur Respir J."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.145982","article-title":"Prenatal exposure to air pollutants and childhood atopic dermatitis and allergic rhinitis adopting machine learning approaches: 14-year follow-up birth cohort study.","volume":"777","author":"Huang","year":"2021","journal-title":"Sci Total Environ."},{"key":"B34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/pde.14405","article-title":"Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis.","volume":"38","author":"Schoch","year":"2021","journal-title":"Pediatr Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ppul.23942","article-title":"Asthma and atopic dermatitis after early-, late-, and post-term birth.","volume":"53","author":"Korhonen","year":"2018","journal-title":"Pediatr Pulmonol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/pai.12050","article-title":"T cell subsets in cord blood are influenced by maternal allergy and associated with atopic dermatitis.","volume":"24","author":"Fu","year":"2013","journal-title":"Pediatr Allergy Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaci.2015.05.035","article-title":"Neonatal adiposity increases the risk of atopic dermatitis during the first year of life.","volume":"137","author":"O\u2019Donovan","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B38","first-page":"1598","article-title":"Dermatitis in early infancy as a risk factor for sensitization and allergic diseases during the first year of life.","volume":"62","author":"Shibuya","year":"2013","journal-title":"Arerugi."},{"key":"B39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000342995","article-title":"Cytokine biomarker candidates in breast milk associated with the development of atopic dermatitis in 6-month-old infants.","volume":"160","author":"Ochiai","year":"2013","journal-title":"Int Arch Allergy Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.2500\/aap.2010.31.3312","article-title":"Eosinophilia as a predictor of food allergy in atopic dermatitis.","volume":"31","author":"Noh","year":"2010","journal-title":"Allergy Asthma Proc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jdv.15157","article-title":"Prevalence, predictors and comorbidity of dry skin in the general population.","volume":"33","author":"Augustin","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jaci.2014.12.013","article-title":"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.","volume":"135","author":"Kelleher","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210013","article-title":"Measurement of trihydroxy-linoleic acids in stratum corneum by tape-stripping: possible biomarker of barrier function in atopic dermatitis.","volume":"14","author":"Chiba","year":"2019","journal-title":"PLoS One."},{"key":"B44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.17219\/acem\/61430","article-title":"Filaggrin loss-of-function mutations as a predictor for atopic eczema, allergic sensitization and eczema-associated asthma in Polish children population.","volume":"26","author":"D\u0119bi\u0144ska","year":"2017","journal-title":"Adv Clin Exp Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2133.2011.10212.x","article-title":"Filaggrin polymorphism P478S, IgE level, and atopic phenotypes.","volume":"164","author":"Wang","year":"2011","journal-title":"Br J Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.12788\/j.sder.2016.041","article-title":"Update on epidemiology, diagnosis, and disease course of atopic dermatitis.","author":"Simpson","year":"2016","journal-title":"Semin Cutan Med Surg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/all.15518","article-title":"Skin biomarkers predict development of atopic dermatitis in infancy.","author":"Rinnov","year":"2022","journal-title":"Allergy."},{"key":"B48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/pai.12410","article-title":"Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS.","volume":"26","author":"Gough","year":"2015","journal-title":"Pediatr Allergy Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/pai.12651","article-title":"Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies.","volume":"28","author":"Alduraywish","year":"2017","journal-title":"Pediatr Allergy Immunol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102879","article-title":"FABP5 as a possible biomarker in atopic march: FABP5-induced Th17 polarization, both in mouse model and human samples.","volume":"58","author":"Lee","year":"2020","journal-title":"EBioMedicine."},{"key":"B51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1468-3083.2010.03812.x","article-title":"An association of TLR2\u201316934A >T polymorphism and severity\/phenotype of atopic dermatitis.","volume":"25","author":"Potaczek","year":"2011","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/all.14461","article-title":"Skin pH-dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity.","volume":"75","author":"H\u00fclp\u00fcsch","year":"2020","journal-title":"Allergy."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jaad.2014.07.031","article-title":"Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.","volume":"71","author":"Landheer","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.anai.2017.06.022","article-title":"Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.","volume":"119","author":"Kim","year":"2017","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041102","article-title":"Squamous cell carcinoma antigen 2 (SCCA2, SERPINB4): an emerging biomarker for skin inflammatory diseases.","volume":"19","author":"Izuhara","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.jaci.2018.01.021","article-title":"SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis.","volume":"141","author":"Nagao","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21040471","article-title":"Aberrant expression of bacterial pattern recognition receptor NOD2 of basophils and microbicidal peptides in atopic dermatitis.","volume":"21","author":"Wong","year":"2016","journal-title":"Molecules."},{"key":"B58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/ACI.0000000000000198","article-title":"Biomarkers for atopic dermatitis: a systematic review and meta-analysis.","volume":"15","author":"Thijs","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jdermsci.2020.10.011","article-title":"The stratum corneum transcriptome in atopic dermatitis can be assessed by tape stripping.","volume":"101","author":"S\u00f8lberg","year":"2021","journal-title":"J Dermatol Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jaci.2017.10.046","article-title":"Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.","volume":"141","author":"Dyjack","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/all.15153","article-title":"Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies.","volume":"77","author":"Andersson","year":"2021","journal-title":"Allergy."},{"key":"B62","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1159\/000512965","article-title":"Interleukin-8 levels in the stratum corneum as a biomarker for monitoring therapeutic effect in atopic dermatitis patients.","volume":"182","author":"Murata","year":"2021","journal-title":"Int Arch Allergy Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000339666","article-title":"Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis.","volume":"160","author":"Amarbayasgalan","year":"2013","journal-title":"Int Arch Allergy Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/all.14490","article-title":"Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin.","volume":"76","author":"Pavel","year":"2021","journal-title":"Allergy."},{"key":"B65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jaip.2020.08.037","article-title":"Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients.","volume":"9","author":"Olesen","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis.","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cei.12021","article-title":"Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis.","volume":"171","author":"Sano","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaci.2020.04.022","article-title":"Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis.","volume":"146","author":"Goleva","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.clindermatol.2013.11.007","article-title":"Atopic dermatitis as a systemic disease.","volume":"32","author":"Darlenski","year":"2014","journal-title":"Clin Dermatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40257-018-0383-4","article-title":"Major comorbidities of atopic dermatitis: beyond allergic disorders.","volume":"19","author":"Paller","year":"2018","journal-title":"Am J Clin Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1398-9995.2009.02010.x","article-title":"Serum interleukin-17 levels are related to clinical severity in allergic rhinitis.","volume":"64","author":"Ciprandi","year":"2009","journal-title":"Allergy."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1365-2222.2012.04068.x","article-title":"Serum IL-23: a surrogate biomarker for asthma.","volume":"42","author":"Ciprandi","year":"2012","journal-title":"Clin Exp Allergy."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jaci.2017.12.991","article-title":"Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.","volume":"141","author":"Thijs","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12265-013-9459-y","article-title":"ST2 as a cardiovascular risk biomarker: from the bench to the bedside.","volume":"6","author":"Januzzi","year":"2013","journal-title":"J Cardiovasc Transl Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.imbio.2015.02.005","article-title":"IL-33\/ST2 axis controls Th2\/IL-31 and Th17 immune response in allergic airway diseases.","volume":"220","author":"Vocca","year":"2015","journal-title":"Immunobiology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/all.12699","article-title":"Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum.","volume":"70","author":"Staudacher","year":"2015","journal-title":"Allergy."},{"key":"B77","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1684\/ejd.2019.3661","article-title":"Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker.","volume":"29","author":"Huang","year":"2019","journal-title":"Eur J Dermatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/jdv.15609","article-title":"Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre.","volume":"33","author":"Olesen","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/all.14080","article-title":"Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry.","volume":"75","author":"Ari\u00ebns","year":"2020","journal-title":"Allergy."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers.","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1159\/000514308","article-title":"Comparison of cytokines in skin biopsies and tape strips from adults with atopic dermatitis.","volume":"237","author":"Simonsen","year":"2021","journal-title":"Dermatology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1028694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T05:02:10Z","timestamp":1668661330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1028694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":81,"alternative-id":["10.3389\/fmed.2022.1028694"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1028694","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"article-number":"1028694"}}